<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Pharm Investig</journal-id><journal-id journal-id-type="iso-abbrev">Int J Pharm Investig</journal-id><journal-id journal-id-type="publisher-id">IJPI</journal-id><journal-title-group><journal-title>International Journal of Pharmaceutical Investigation</journal-title></journal-title-group><issn pub-type="ppub">2230-973X</issn><issn pub-type="epub">2230-9713</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28929051</article-id><article-id pub-id-type="pmc">5553269</article-id><article-id pub-id-type="publisher-id">IJPI-7-88</article-id><article-id pub-id-type="doi">10.4103/jphi.JPHI_19_17</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research Article</subject></subj-group></article-categories><title-group><article-title>Comparison of effectiveness of <italic>Calendula officinalis</italic> extract gel with lycopene gel for treatment of tobacco-induced homogeneous leukoplakia: A randomized clinical trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Singh</surname><given-names>Manisha</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Bagewadi</surname><given-names>Anjana</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Oral Medicine and Radiology, KLE Vishwanath Katti Institute of Dental Sciences, Belagavi, Karnataka, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Manisha Singh, Department of Oral Medicine and Radiology, KLE Vishwanath Katti Institute of Dental Sciences, Nehru Nagar, Belagavi - 590 010, Karnataka, India. E-mail: <email xlink:href="Manishasingh1831988@gmail.com">Manishasingh1831988@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Apr-Jun</season><year>2017</year></pub-date><volume>7</volume><issue>2</issue><fpage>88</fpage><lpage>93</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2017 International Journal of Pharmaceutical Investigation</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Aim:</title><p>The aim of the study is to assess the efficacy of <italic>Calendula officinalis</italic> gel as cost-effective treatment modality in comparison to lycopene gel in the treatment of leukoplakia.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>The study comprised of sixty patients of clinically diagnosed and histopathologically confirmed cases of homogeneous leukoplakia which were divided into Group I and Group II with thirty patients each. Group I patients were dispensed <italic>C. officinalis</italic> extract gel whereas Group II patients were given lycopene gel. The therapy was instituted for 1 month to assess the change in the size of the lesion at the baseline and posttreatment.</p></sec><sec id="st3"><title>Results:</title><p>The results revealed a statistically significant difference in both Group I and Group II when the pre- and post-treatment results were compared in the same group. The mean difference in the reduction in size before and after treatment for Group I was 2.0% &#x000b1;1.0 cm while for the Group II, it was 1.57% &#x000b1;0.87 cm. The intergroup comparison for the evaluation of reduction in the size of the lesion did not reveal statistically significant results.</p></sec><sec id="st4"><title>Conclusion:</title><p><italic>C. officinalis</italic> extract gel can be effectively used as an alternative to conventional treatment modality.</p></sec></abstract><kwd-group><title>Keywords</title><kwd><italic>Calendula officinalis</italic></kwd><kwd>leukoplakia</kwd><kwd>lycopene</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Oral leukoplakia (OL) is one among important potentially malignant disorders of the oral mucosa.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] Leukoplakia may occur anywhere on the oral mucosa, and its prevalence varies from 0.2% to 5.2% of the Indian population.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref>] The tobacco chewing habit both in smoking and smokeless form is the most common cause for OL. Many oral squamous cell carcinomas develop from potentially malignant disorders.[<xref rid="ref5" ref-type="bibr">5</xref>] It has been reported that between 16% and 62% of oral squamous cell carcinomas are associated with OL.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref6" ref-type="bibr">6</xref>] Early diagnosis and treatment of these potentially malignant disorders is required to prevent their progression to malignancy. Hence, it is important for the clinician to diagnose leukoplakia in its initial stages and manage effectively.</p><p>Current treatment modalities include cessation of tobacco chewing habit and lycopene as a powerful antioxidant, a member of carotenoid family of phytochemicals obtained from tomatoes, other red fruits and vegetables (red carrots, watermelons, papayas).[<xref rid="ref7" ref-type="bibr">7</xref>] Lycopene exhibits the highest physical quenching rate constant with singlet oxygen, thereby known for its antioxidizing property.[<xref rid="ref8" ref-type="bibr">8</xref>] The conjugated polyene structure of lycopene provides an electron-rich system which neutralizes harmful free radicals and prevents cell death.[<xref rid="ref9" ref-type="bibr">9</xref>] Tomato products and lycopene consumption reduce the risk of upper aerodigestive tract cancers of oral cavities, pharynx, larynx, and esophagus.[<xref rid="ref10" ref-type="bibr">10</xref>] The ability of lycopene is supposed to modify intercellular exchange junctions, thereby effective in potentially malignant disorders.[<xref rid="ref11" ref-type="bibr">11</xref>]</p><p>Many herbal medicines have been tried in the management of oral diseases including premalignant disorders. <italic>Calendula officinalis</italic> is one among the herbal medicines which has the potential antioxidant property. <italic>C. officinalis</italic> also known as pot marigold is an annual herb belonging to family <italic>Asteraceae</italic>.[<xref rid="ref12" ref-type="bibr">12</xref>] Pharmacological studies have confirmed that <italic>C. officinalis</italic> has a broad range of biological activity such as antimicrobial, anti-inflammatory, immunomodulatory, wound healing, antiviral, and antitumoral property.[<xref rid="ref13" ref-type="bibr">13</xref>]</p><p>Research has shown that <italic>C. officinalis</italic> contains flavonoids, polyphenols, lutein, flavoxanthin, lycopene, auroxanthin, beta-carotene which possesses antioxidant property[<xref rid="ref14" ref-type="bibr">14</xref>] and hence can be utilized in the treatment of leukoplakia. In the light of above properties of <italic>C. officinalis</italic>, this study was proposed to assess the effect of herbal gel in treatment of homogeneous leukoplakia. This gel is a cost-effective treatment modality when compared with lycopene gel for the treatment of homogeneous leukoplakia.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><p>Sixty patients of either sex with clinically diagnosed and histopathologically confirmed cases of homogeneous leukoplakia were selected reporting to the Department of Oral Medicine and Radiology, KLE Vishwanath Katti Institute of Dental Sciences and Research Centre, Belagavi. Informed consent was obtained from all the patients, and approval was seeked from the Institutional Ethical Committee and review board of KLE Vishwanath Katti Institute of Dental Sciences, Belagavi. Individuals willing to participate in the study with the signed informed consent were included in the study. Patients with potentially malignant disorders other than homogeneous leukoplakia, any past history of major illness within a period of 6 months, allergy to <italic>Asteraceae</italic> family and lycopene were excluded from the study.</p><p>Patients included 60 clinically and histopathologically confirmed cases of homogeneous leukoplakia based on the classification given by Warnakulasuriya S <italic>et al</italic>. (2007)[<xref rid="ref15" ref-type="bibr">15</xref>] which were randomly divided into following 2 Groups with thirty patients each. Patients in Group I were dispensed <italic>C. officinalis</italic> gel containing antioxidants 2 mg by weight, per gram of gel. Patients in Group II were dispensed lycopene gel containing lycopene antioxidant 2 mg by weight, per gram of gel.</p><p>The double-blinded protocol was followed in which both the patient and the investigator were unknown about the medication given. Tobacco cessation counseling was done for all the patients at the very first appointment and they were instructed to apply the gel thrice daily after breakfast, lunch and dinner for a period of 1 month [<xref ref-type="fig" rid="F1">Figure 1</xref>]. Both the gels were dispensed in a sterile plastic bottle with a nozzle. Patients were instructed to use sterile ear buds for gel application at the site of the lesion. Patients were also demonstrated about the quantity and method of gel application on the lesion at the first appointment itself.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Application of gel at the site of lesion</p></caption><graphic xlink:href="IJPI-7-88-g001"/></fig><p>The therapy was followed up for the next 3 months. Patients were examined on the 30<sup>th</sup> day to assess the change in the size of the lesion at the baseline [<xref ref-type="fig" rid="F2">Figure 2</xref>] and posttreatment [<xref ref-type="fig" rid="F3">Figure 3</xref>]. The evaluation of the treatment was assessed by quantitative bidimensional measurement using clinical photographs of the lesion and measuring the size of the lesion by Photoshop software version 5. The two longest diameters calculated by the software were used to calculate the total size of the lesion. The measurements were done twice, first at the baseline (before application of the gel) and at the posttreatment (end of 1 month). The data obtained were statistically analyzed using paired <italic>t</italic>-test to evaluate the correlation in <italic>C. officinalis</italic> group and lycopene group (pre- and post-treatment), and unpaired <italic>t</italic>-test was done to evaluate the correlation between <italic>C. officinalis</italic> and lycopene group (posttreatment).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Pretreatment homogeneous leukoplakia</p></caption><graphic xlink:href="IJPI-7-88-g002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Posttreatment after application of <italic>C. officinalis</italic> gel</p></caption><graphic xlink:href="IJPI-7-88-g003"/></fig><sec id="sec2-1"><title>Gel preparation</title><p><italic>C. officinalis</italic> flowers were collected from Horticulture Department (Civil) NTPC Barh, Patna, during November 2015. Flowers were authenticated by the trained and experienced faculty of Regional Medical Research Centre, Nehru Nagar, Belagavi, and the herbarium specimen was deposited at ICMR with accession number RMRC-1280. Other chemicals such as Hydroxymethyl propyl cellulose, methyl paraben, and propyl paraben used in the formulations were of analytical grade procured from the local dealers at Belagavi. The material for lycopene gel was procured from Lycored Jagsonpal Pharmaceutics Limited. <italic>C. officinalis</italic> and lycopene gels were prepared in the Department of Pharmaceutics, KLEU college of Pharmacy, Belagavi.</p></sec><sec id="sec2-2"><title>Per gram of <italic>Calendula officinalis</italic> gel contained</title><p>
<list list-type="bullet"><list-item><p>Compound extract-2 mg by weight</p></list-item><list-item><p>Gelling agent-hydroxymethyl propyl cellulose (5% w/v)</p></list-item><list-item><p>Preservative-methyl paraben (0.1% w/v), propylparaben (0.01% w/v)</p></list-item><list-item><p>Humectant-glycerine (5% w/v)</p></list-item><list-item><p>Solvent for menthol-ethanol (2 drops)</p></list-item><list-item><p>Sweetening agent-xylitol (1% w/v)</p></list-item><list-item><p>Flavoring agent-menthol (0.05% w/v).</p></list-item></list>
</p></sec><sec id="sec2-3"><title>Per gram of lycopene gel contained</title><p>
<list list-type="bullet"><list-item><p>Compound-2 mg by weight</p></list-item><list-item><p>Thickening agent-sodium alginate (0.3% w/v), calcium gluconate (0.005% w/v)</p></list-item><list-item><p>Sweetener-Sodium saccharin (0.1% w/v)</p></list-item><list-item><p>Humectant-glycerine (5% w/v)</p></list-item><list-item><p>Flavoring agent-peppermint oil (0.001% w/v).</p></list-item></list>
</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>In the present study, the majority of the patients in Group I and Group II were males. There were 28 males and 2 females in Group I and 22 males and 8 females in Group II [<xref ref-type="table" rid="T1">Table 1</xref>]. The majority of patients in Group I and Group II were in the age group of 56&#x02013;65 years [<xref ref-type="table" rid="T2">Table 2</xref>]. No significant difference was present in Group I and Group II in regard to age and gender.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Sex distribution in Group I and Group II</p></caption><graphic xlink:href="IJPI-7-88-g004"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Age distribution in Group I and Group II</p></caption><graphic xlink:href="IJPI-7-88-g005"/></table-wrap><p>The average size of leukoplakia before treatment was 4.14 cm<sup>2</sup> (standard deviation [SD] = 2.07) and after treatment was 2.09 cm<sup>2</sup> (SD = 2.59) in Group I [<xref ref-type="fig" rid="G1">Graph 1</xref>]. The average size of leukoplakia before treatment was 4.46 cm<sup>2</sup> (SD = 2.41) and after treatment, it was 2.89 cm<sup>2</sup> (SD = 3.07) in Group II. The mean difference in the reduction in size before and after treatment for Group I was 2.0 &#x000b1; 1.0 cm while for the Group II, it was 1.57 &#x000b1; 0.87 cm [<xref ref-type="table" rid="T3">Table 3</xref>].</p><fig id="G1" position="float"><label>Graph 1</label><caption><p>Comparison of change in size after <italic>C. officinalis</italic> gel application</p></caption><graphic xlink:href="IJPI-7-88-g006"/></fig><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison of mean&#x000b1;SD of size (cm) of lesion in Group I and II (pre- and post-treatment)</p></caption><graphic xlink:href="IJPI-7-88-g007"/></table-wrap><p>There was statistically significant difference in both Group I and Group II when the pre- and post-treatment results were compared in the same group. However, no significant difference was observed between the two groups.</p></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Leukoplakia is one of the most common potentially malignant disorders of the oral mucosa.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref15" ref-type="bibr">15</xref>] The annual malignant transformation rate of OL ranges between 3% and 17.5%.[<xref rid="ref15" ref-type="bibr">15</xref>]</p><p>Leukoplakia is more common among the elderly men over 40 years of age, and its prevalence increases with age.[<xref rid="ref16" ref-type="bibr">16</xref>] In the present study, the majority of patients of OL were above 55 years of age, and a higher male predominance was seen. B&#x000e1;n&#x000f3;czy also reported the prevalence of leukoplakia in the age group of 51&#x02013;60 years with higher male predominance.[<xref rid="ref17" ref-type="bibr">17</xref>] Espinoza <italic>et al</italic>. also concluded that there was higher prevalence of leukoplakia in men after 50 years of age.[<xref rid="ref18" ref-type="bibr">18</xref>] Liu <italic>et al</italic>. conducted a study on 218 patients of leukoplakia and reported that peak incidence was during the fifth decade of life.[<xref rid="ref19" ref-type="bibr">19</xref>] Brouns <italic>et al</italic>. found the mean age of 57 years among 275 patients of leukoplakia.[<xref rid="ref20" ref-type="bibr">20</xref>] A study done by Gupta <italic>et al</italic>. also showed the annual incidence of 1.1%&#x02013;2.4% among men and 0.2%&#x02013;0.03% among women.[<xref rid="ref21" ref-type="bibr">21</xref>] Various other investigators like Waldron and Shafer[<xref rid="ref22" ref-type="bibr">22</xref>] and Mohitpal Singh <italic>et al</italic>.[<xref rid="ref8" ref-type="bibr">8</xref>] also reported male predominance for OL.</p><p>In the present study, patients in Group II (<italic>n</italic> = 30) were dispensed lycopene gel. The treatment was instituted for 1 month and followed up for another 3 months. The results of the study showed significant reduction in the size of the lesion with no side effects. Similar results were reported by Mohitpal Singh <italic>et al</italic>. who compared two different doses of systemic lycopene (8 mg/day and 4 mg/day) with placebo in the treatment of leukoplakia and stated that patients receiving lycopene in both groups showed a significant reduction in size as compared to the placebo group.[<xref rid="ref8" ref-type="bibr">8</xref>]</p><p>The effectiveness of lycopene has also been evaluated in combination with micronutrients, and significant results are reported. Patel <italic>et al</italic>. found that lycopene in combination with Vitamin E and selenium was effective in reducing the clinical size of the lesion in patients with leukoplakia.[<xref rid="ref23" ref-type="bibr">23</xref>] Studies carried out by investigators like Nagasawa <italic>et al</italic>.,[<xref rid="ref24" ref-type="bibr">24</xref>] Sharoni <italic>et al</italic>.,[<xref rid="ref25" ref-type="bibr">25</xref>] Narisawa <italic>et al</italic>.,[<xref rid="ref26" ref-type="bibr">26</xref>] and Bhuvaneshwari <italic>et al</italic>.[<xref rid="ref27" ref-type="bibr">27</xref>] have suggested lycopene to be an effective agent in inhibiting carcinogenesis.</p><p>Several herbal products have been used in the treatment of leukoplakia, and their effectiveness is well documented in the literature. Palak H <italic>et al</italic>. concluded the role of curcumin in treating precancerous lesions.[<xref rid="ref28" ref-type="bibr">28</xref>] Deshpande <italic>et al</italic>. evaluated the effect of Triphala mouth rinse on the reversal of precancerous lesions and reported significant results.[<xref rid="ref28" ref-type="bibr">28</xref>] Mathew <italic>et al</italic>. evaluated the effectiveness of Spirulina fusiformis in the chemoprevention of oral cancer. Complete regression of lesions was observed in 16 of 28 (57%) patients supplemented with Spirulina of patients with homogeneous leukoplakia.[<xref rid="ref29" ref-type="bibr">29</xref>]</p><p>Considering the promising effects of herbal medicine in the treatment of leukoplakia, the present study was undertaken to evaluate and compare the effectiveness of <italic>C. officinalis</italic> extract with lycopene and to propose it as an innocuous, cheap, and easily available treatment modality for the treatment of leukoplakia. There is no evidence in literature about any study done to evaluate the effectiveness of <italic>C. officinalis</italic> extract in the management of leukoplakia, and hence, this is the first study.</p><p>In the present study, all the 30 patients in <italic>C. officinalis</italic> group demonstrated significant reduction in the size of the lesion in 1 month. The significant differences obtained in Group I indicate that <italic>C. officinalis</italic> extract can be readily used as an effective treatment modality in the management of leukoplakia. However, no significant differences were seen between the <italic>C. officinalis</italic> and lycopene group thus indicating that both the drugs are equally effective and can be successfully employed in the treatment of homogeneous leukoplakia. Patients were followed up for a period of 4 months to evaluate the stability in the reduction of size and record any recurrences.</p><p>In future, further studies should be carried out by modifying the concentration of <italic>C. officinalis</italic> gel and following up with histopathological changes.</p></sec><sec sec-type="conclusions" id="sec1-5"><title>CONCLUSION</title><p>Thus, it can be concluded that <italic>C. officinalis</italic> extract can be effectively used as an alternative to conventional treatment modality. Looking at the promising results of the study, initiative should be taken in collaboration with herbal healthcare companies to introduce <italic>C. officinalis</italic> extract at a commercial level so that it is easily available for the patients. Further studies with larger sample size can determine optimal therapeutic dose levels and frequency of administration to improve effectiveness.</p><sec id="sec2-4"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-5" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ack><title>Acknowledgment</title><p>We would like to acknowledge Mr. Udayakumar Bolmal Asst. Professor, Department of Pharmaceutics, KLEU college of pharmacy, Belagavi, for providing with the preparation of gel and carrying the study.</p></ack><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouns</surname><given-names>E</given-names></name><name><surname>Baart</surname><given-names>J</given-names></name><name><surname>Karagozoglu</surname><given-names>KH</given-names></name><name><surname>Aartman</surname><given-names>I</given-names></name><name><surname>Bloemena</surname><given-names>E</given-names></name><name><surname>van der Waal</surname><given-names>I</given-names></name></person-group><article-title>Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients</article-title><source>Oral Dis</source><year>2014</year><volume>20</volume><fpage>e19</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">23521625</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parlatescu</surname><given-names>I</given-names></name><name><surname>Gheorghe</surname><given-names>C</given-names></name><name><surname>Coculescu</surname><given-names>E</given-names></name><name><surname>Tovaru</surname><given-names>S</given-names></name></person-group><article-title>Oral leukoplakia &#x02013; An update</article-title><source>Maedica (Buchar)</source><year>2014</year><volume>9</volume><fpage>88</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">25553134</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>KS</given-names></name><name><surname>Gupta</surname><given-names>PC</given-names></name></person-group><article-title>Economic history of tobacco production: From colonial origins to contemporary trends</article-title><source>Report on Tobacco Control in India. Joint Report Supported by Ministry of Health and Family Welfare, Government of India, Centre of Disease Control and Prevention</source><year>2004</year><volume>2</volume><publisher-loc>USA</publisher-loc><publisher-name>World Health Organization</publisher-name><fpage>19</fpage><lpage>32</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radwan-Oczko</surname><given-names>M</given-names></name><name><surname>Mendak</surname><given-names>M</given-names></name></person-group><article-title>Differential diagnosis of oral leukoplakia and lichen planus &#x02013; On the basis of literature and own observations</article-title><source>J Stomatol</source><year>2011</year><volume>64</volume><fpage>355</fpage><lpage>70</lpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortazavi</surname><given-names>H</given-names></name><name><surname>Baharvand</surname><given-names>M</given-names></name><name><surname>Mehdipour</surname><given-names>M</given-names></name></person-group><article-title>Oral potentially malignant disorders: An overview of more than 20 entities</article-title><source>J Dent Res Dent Clin Dent Prospects</source><year>2014</year><volume>8</volume><fpage>6</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">25024833</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouns</surname><given-names>E</given-names></name><name><surname>Baart</surname><given-names>JA</given-names></name><name><surname>Bloemena</surname><given-names>E</given-names></name><name><surname>Karagozoglu</surname><given-names>H</given-names></name><name><surname>Waal</surname><given-names>I</given-names></name></person-group><article-title>The relevance of uniform reporting in oral leukoplakia: Definition, certainty factor and staging based on experience with 275 patients</article-title><source>Med Oral Patol Oral Cir Bucal</source><year>2013</year><volume>18</volume><fpage>e19</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">23085711</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manigandan</surname><given-names>T</given-names></name><name><surname>Hemalatha</surname><given-names>VT</given-names></name></person-group><article-title>Insight of various medical management of oral leukoplakia</article-title><source>Biomed Pharmacol J</source><year>2015</year><volume>8</volume><fpage>393</fpage><lpage>401</lpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Krishanappa</surname><given-names>R</given-names></name><name><surname>Bagewadi</surname><given-names>A</given-names></name><name><surname>Keluskar</surname><given-names>V</given-names></name></person-group><article-title>Efficacy of oral lycopene in the treatment of oral leukoplakia</article-title><source>Oral Oncol</source><year>2004</year><volume>40</volume><fpage>591</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15063387</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzapfel</surname><given-names>NP</given-names></name><name><surname>Holzapfel</surname><given-names>BM</given-names></name><name><surname>Champ</surname><given-names>S</given-names></name><name><surname>Feldthusen</surname><given-names>J</given-names></name><name><surname>Clements</surname><given-names>J</given-names></name><name><surname>Hutmacher</surname><given-names>DW</given-names></name></person-group><article-title>The potential role of lycopene for the prevention and therapy of prostate cancer: From molecular mechanisms to clinical evidence</article-title><source>Int J Mol Sci</source><year>2013</year><volume>14</volume><fpage>14620</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">23857058</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Stefani</surname><given-names>E</given-names></name><name><surname>Oreggia</surname><given-names>F</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name><name><surname>Deneo-Pellegrini</surname><given-names>H</given-names></name><name><surname>Ronco</surname><given-names>A</given-names></name><name><surname>Mendilaharsu</surname><given-names>M</given-names></name></person-group><article-title>Tomatoes, tomato-rich foods, lycopene and cancer of the upper aerodigestive tract: A case-control in Uruguay</article-title><source>Oral Oncol</source><year>2000</year><volume>36</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">10889919</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>AV</given-names></name><name><surname>Agarwal</surname><given-names>S</given-names></name></person-group><article-title>Role of antioxidant lycopene in cancer and heart disease</article-title><source>J Am Coll Nutr</source><year>2000</year><volume>19</volume><fpage>563</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11022869</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernatoniene</surname><given-names>J</given-names></name><name><surname>Masteikova</surname><given-names>R</given-names></name><name><surname>Davalgiene</surname><given-names>J</given-names></name></person-group><article-title>Topical application of <italic>Calendula officinalis</italic> (L.): Formulation and evaluation of hydrophilic cream with antioxidant activity</article-title><source>J Med Plants Res</source><year>2011</year><volume>5</volume><fpage>868</fpage><lpage>77</lpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muley</surname><given-names>BP</given-names></name><name><surname>Khadabadi</surname><given-names>SS</given-names></name><name><surname>Banarase</surname><given-names>NB</given-names></name></person-group><article-title>Phytochemical constituents and pharmacological activities of <italic>Calendula officinalis</italic> Linn (<italic>Asteraceae</italic>): A review</article-title><source>Trop J Pharm Res</source><year>2009</year><volume>8</volume><fpage>455</fpage><lpage>65</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozkol</surname><given-names>H</given-names></name><name><surname>T&#x000fc;l&#x000fc;ce</surname><given-names>Y</given-names></name><name><surname>Koyuncu</surname><given-names>I</given-names></name></person-group><article-title>Subacute effect of cigarette smoke exposure in rats: Protection by pot marigold (<italic>Calendula officinalis</italic> L.) extract</article-title><source>Toxicol Ind Health</source><year>2012</year><volume>28</volume><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21505008</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warnakulasuriya</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>NW</given-names></name><name><surname>van der Waal</surname><given-names>I</given-names></name></person-group><article-title>Nomenclature and classification of potentially malignant disorders of the oral mucosa</article-title><source>J Oral Pathol Med</source><year>2007</year><volume>36</volume><fpage>575</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">17944749</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napier</surname><given-names>SS</given-names></name><name><surname>Speight</surname><given-names>PM</given-names></name></person-group><article-title>Natural history of potentially malignant oral lesions and conditions: An overview of the literature</article-title><source>J Oral Pathol Med</source><year>2008</year><volume>37</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">18154571</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e1;n&#x000f3;czy</surname><given-names>J</given-names></name></person-group><article-title>Follow-up studies in oral leukoplakia</article-title><source>J Maxillofac Surg</source><year>1977</year><volume>5</volume><fpage>69</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">265354</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinoza</surname><given-names>I</given-names></name><name><surname>Rojas</surname><given-names>R</given-names></name><name><surname>Aranda</surname><given-names>W</given-names></name><name><surname>Gamonal</surname><given-names>J</given-names></name></person-group><article-title>Prevalence of oral mucosal lesions in elderly people in Santiago, Chile</article-title><source>J Oral Pathol Med</source><year>2003</year><volume>32</volume><fpage>571</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">14632931</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><name><surname>Zhou</surname><given-names>HW</given-names></name><name><surname>Shi</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>ZT</given-names></name><name><surname>Tang</surname><given-names>GY</given-names></name></person-group><article-title>Malignant transformation of oral leukoplakia: A retrospective cohort study of 218 Chinese patients</article-title><source>BMC Cancer</source><year>2010</year><volume>10</volume><fpage>685</fpage><pub-id pub-id-type="pmid">21159209</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouns</surname><given-names>ER</given-names></name><name><surname>Baart</surname><given-names>JA</given-names></name><name><surname>Bloemena</surname><given-names>E</given-names></name><name><surname>Karagozoglu</surname><given-names>H</given-names></name><name><surname>van der Waal</surname><given-names>I</given-names></name></person-group><article-title>The relevance of uniform reporting in oral leukoplakia: Definition, certainty factor and staging based on experience with 275 patients</article-title><source>Med Oral Patol Oral Cir Bucal</source><year>2013</year><volume>18</volume><fpage>e19</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">23085711</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>PC</given-names></name><name><surname>Mehta</surname><given-names>FS</given-names></name><name><surname>Daftary</surname><given-names>DK</given-names></name><name><surname>Pindborg</surname><given-names>JJ</given-names></name><name><surname>Bhonsle</surname><given-names>RB</given-names></name><name><surname>Jalnawalla</surname><given-names>PN</given-names></name><etal/></person-group><article-title>Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers</article-title><source>Community Dent Oral Epidemiol</source><year>1980</year><volume>8</volume><fpage>283</fpage><lpage>333</lpage></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldron</surname><given-names>CA</given-names></name><name><surname>Shafer</surname><given-names>WG</given-names></name></person-group><article-title>Current concepts of oral leukoplakia</article-title><source>Int Dent J</source><year>1960</year><volume>10</volume><fpage>352</fpage><lpage>67</lpage></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>JS</given-names></name><name><surname>Umarji</surname><given-names>HR</given-names></name><name><surname>Dhokar</surname><given-names>AA</given-names></name></person-group><article-title>Randomized controlled trial to evaluate the efficacy of oral lycopene in combination with Vitamin E and selenium in the treatment of oral leukoplakia</article-title><source>J Indian Acad Oral Med Radiol</source><year>2014</year><volume>26</volume><fpage>369</fpage><lpage>73</lpage></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagasawa</surname><given-names>H</given-names></name><name><surname>Mitamura</surname><given-names>T</given-names></name><name><surname>Sakamoto</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name></person-group><article-title>Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice</article-title><source>Anticancer Res</source><year>1995</year><volume>15</volume><fpage>1173</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7653996</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharoni</surname><given-names>Y</given-names></name><name><surname>Giron</surname><given-names>E</given-names></name><name><surname>Rise</surname><given-names>M</given-names></name><name><surname>Levy</surname><given-names>J</given-names></name></person-group><article-title>Effects of lycopene-enriched tomato oleoresin on 7,12-dimethyl-benz[a] anthracene-induced rat mammary tumors</article-title><source>Cancer Detect Prev</source><year>1997</year><volume>21</volume><fpage>118</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">9101071</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narisawa</surname><given-names>T</given-names></name><name><surname>Fukaura</surname><given-names>Y</given-names></name><name><surname>Hasebe</surname><given-names>M</given-names></name><name><surname>Nomura</surname><given-names>S</given-names></name><name><surname>Oshima</surname><given-names>S</given-names></name><name><surname>Sakamoto</surname><given-names>H</given-names></name><etal/></person-group><article-title>Prevention of N-methylnitrosourea-induced colon carcinogenesis in F344 rats by lycopene and tomato juice rich in lycopene</article-title><source>Jpn J Cancer Res</source><year>1998</year><volume>89</volume><fpage>1003</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9849577</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhuvaneswari</surname><given-names>V</given-names></name><name><surname>Velmurugan</surname><given-names>B</given-names></name><name><surname>Balasenthil</surname><given-names>S</given-names></name><name><surname>Ramachandran</surname><given-names>CR</given-names></name><name><surname>Nagini</surname><given-names>S</given-names></name></person-group><article-title>Chemopreventive efficacy of lycopene on 7,12-dimethylbenz[a] anthracene-induced hamster buccal pouch carcinogenesis</article-title><source>Fitoterapia</source><year>2001</year><volume>72</volume><fpage>865</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">11731111</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>PH</given-names></name><name><surname>Venkatesh</surname><given-names>R</given-names></name></person-group><article-title>Curcumin: A magic spice for oral potentially malignant disorders</article-title><source>Int J Phytother</source><year>2015</year><volume>5</volume><fpage>44</fpage><lpage>7</lpage></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>B</given-names></name><name><surname>Sankaranarayanan</surname><given-names>R</given-names></name><name><surname>Nair</surname><given-names>PP</given-names></name><name><surname>Varghese</surname><given-names>C</given-names></name><name><surname>Somanathan</surname><given-names>T</given-names></name><name><surname>Amma</surname><given-names>BP</given-names></name><etal/></person-group><article-title>Evaluation of chemoprevention of oral cancer with spirulina fusiformis</article-title><source>Nutr Cancer</source><year>1995</year><volume>24</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">8584455</pub-id></element-citation></ref></ref-list></back></article>